Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of Ozempic’s highest dose, according to new clinical trial results. Professor Donal O'Shea, Anti-Obesity Specialist on the results of this study.

<p>Eli Lilly’s next generation weight loss drug, known as retatrutide, was shown to provide more than double the weight loss of Ozempic’s highest dose, according to new clinical trial results. Professor Donal O'Shea, Anti-Obesity Specialist on the results of this study.</p>

News, sport, business and interviews. Presented by Rachael English. Listen live Monday to Friday at 1pm on RTÉ Radio 1.

News at One

News, sport, business and interviews. Presented by Rachael English.

<p>News, sport, business and interviews. Presented by Rachael English.</p>